1. Safety is 'top of the list' for Covid-19 vaccine – Oxford scientist  North Wales Chronicle
  2. Pfizer CEO says company will know if vaccine works by end of October  CBS News
  3. View Full coverage on Google News
A jab could be ready by the end of this year or early next year if things fall into place, Professor Sarah Gilbert said.A jab could be ready by the end of this year or early next year if things fall into place, Professor Sarah Gilbert said.

Safety is ‘top of the list’ for Covid-19 vaccine – Oxford scientist | North Wales Chronicle

The country has four Covid-19 vaccines in the final stage of clinical trials.The country has four Covid-19 vaccines in the final stage of clinical trials.

China coronavirus vaccine may be ready for public in November: official - World - DAWN.COM

Experts say direct delivery to the lungs may give a better immune response.Experts say direct delivery to the lungs may give a better immune response.

Coronavirus: UK to test inhaled vaccines - BBC News

AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday.AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday.

AstraZeneca resumes COVID-19 vaccine trials in South Africa, health dept says | Reuters

Researchers say monopolizing a COVID vaccine could cause more deaths. China vaccine could be ready by Nov. 194K US deaths. Latest coronavirus updates.Researchers say monopolizing a COVID vaccine could cause more deaths. China vaccine could be ready by Nov. 194K US deaths. Latest coronavirus updates.

COVID News: Trump owes $28M to USPS; China vaccine by Nov, Dec

Gulf News Zero Campaign aims to raise awareness to help the country flatten the curveGulf News Zero Campaign aims to raise awareness to help the country flatten the curve

COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials – Gulf News

Mary Kate Rylands discusses the power dynamics surrounding the search for a Covid-19 vaccine.

Power, populism and cooperation: the politicisation of vaccines | Palatinate Online

Director of the Chinese Center for Disease Control and Prevention, Dr Gao Fu, said nationwide coronavirus vaccinations would only be necessary if there was another major outbreak.Director of the Chinese Center for Disease Control and Prevention, Dr Gao Fu, said nationwide coronavirus vaccinations would only be necessary if there was another major outbreak.

China will not carry out mass vaccinations on its population, Beijing's health chief says  | Daily Mail Online

The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval - WSJ

egypttoday,Politics,Business,Economy,Art,culture,Local news,Special interest,Press Review,News,ResourcesHead of the Russian Direct Investment Fund Kirill Dmitriev said Tuesday that Egypt is one of Russia’s main partners in the region.

Egypt to be gate for "Sputnik V" vaccine to Africa: Russian official - Egypt Today

50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...

Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven' - Sputnik International

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

“The complications are described in the instructions and are predictable,” Russia's health minister said.“The complications are described in the instructions and are predictable,” Russia's health minister said.

1 in 7 Russian Coronavirus Vaccine Volunteers Report Side Effects - The Moscow Times

The studies were paused for less than a week.The studies were paused for less than a week.

AstraZeneca Resumes U.K. Clinical Trials of Its Coronavirus Vaccine After a Safety Pause | The Motley Fool

Trials of AstraZeneca Covid-19 vaccine remain on hold until midweekTrials of AstraZeneca Covid-19 vaccine remain on hold until midweek

Coronavirus: Global infections approach 30 million

Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Experts call the global response to the COVID-19 pandemic a "collective failure."Experts call the global response to the COVID-19 pandemic a "collective failure."

Pandemic total passes 29 million as cases hit daily high | CIDRAP

Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature, Russian Health Minister Mikhail Murashko said on Tuesday. "Over 300 persons have been vaccinated.

Over 300 Volunteers Get Russian COVID-19 Vaccine - Novinite.com - Sofia News Agency

DUBAI: The UAE on Monday granted emergency approval for health workers to use a COVID-19 vaccine currently in its third phase of testing. Health minister Abdulrahman Al-Owais said the vaccine would be available for “first-line-of-defense heroes, who are most at risk of catching COVID-19, protecting them from any danger that they may be exposed to due to the nature of theirDUBAI: The UAE on Monday granted emergency approval for health workers to use a COVID-19 vaccine currently in its third phase of testing. Health minister Abdulrahman Al-Owais said the vaccine would

UAE approves COVID-19 vaccine for health workers | Arab News

The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...

Coronavirus update: Global cases edge toward 30 million, and China says vaccine may be ready by November - MarketWatch

The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. 

Valneva signs $1.6B supply, development agreement with U.K. for coronavirus vaccine hopeful | FiercePharma

The suspension of a leading coronavirus vaccine trial had dashed investors' hopes of economic recovery worldwide, but the trial will now continue.The suspension of a leading coronavirus vaccine trial had dashed investors' hopes of economic recovery worldwide, but the trial will now continue.

Stocks rise as AstraZeneca resumes vaccine trial

Bloomberg - Are you a robot?

In March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signedIn March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signed up to be the first volunteers to receive jab…

Debate rages over China's Covid-19 vaccines - Asia Times

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been releasedUK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency - Scientific American

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

The United Arab Emirates (UAE) on Monday granted emergency approval for use of a coronavirus vaccine developed in China, six weeks after human trials on the vaccine started in the country.

UAE approves urgent use of China-developed COVID-19 vaccine after test on 31,000 volunteers - Global Times

Coronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 millionCoronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 million

Global report: Covid cases near 30m as China expects vaccine as soon as November | Coronavirus outbreak | The Guardian

A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up. And on late Monday, the chief biosafety expert at the Chinese Centre for Disease Control told state broadcaster CCTV that a vaccine would be available to the general public "around November or December."

China says Covid-19 vaccine could be ready for public by November

Emergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures - ZAWYA MENA EditionEmergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures

The vaccine trial remains on hold pending a US FDA investigation into a serious side effect in the UK - sources. The vaccine trial remains on hold pending a US FDA investigation into a serious side effect in the UK - sources.

AstraZeneca COVID-19 vaccine trial in US remains on hold | News | Al Jazeera

NHK has learned that British pharmaceutical giant AstraZeneca plans to resume clinical trials of a coronavirus vaccine in Japan soon, following their resumption in Britain.NHK has learned that British pharmaceutical giant AstraZeneca plans to resume clinical trials of a coronavirus vaccine in Japan soon, following their resumption in Britain.

AstraZeneca to resume vaccine trials in Japan | NHK WORLD-JAPAN News

The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.

COVID-19: China prioritises frontline workers, says no need to vaccinate entire population - Republic World

403 Forbidden

China's COVID-19 vaccine could be ready for public in November: expert - CGTN

'It will be very soon. The progress is currently very smooth,' said a Chinese official.'It will be very soon. The progress is currently very smooth,' said a Chinese official.

Coronavirus vaccine in China could be ready by November say officials - Business Insider

Following a swift independent investigation, large-scale trials for a COVID-19 vaccine developed by scientists at the University of Oxford are recommencing across the UK after a suspected adverse reaction triggered a global halt to trials last week.Following a swift independent investigation by the Medicines Health Regulatory Authority (MHRA), large-scale Phase 3 trials for a COVID-19 vaccine developed by scientists at the University of Oxford, are recommencing across the United Kingdom after a suspected adverse reaction triggered a global halt to trials last week.

Oxford’s COVID-19 vaccine trial resumes in UK

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.

Biopharma Update on the Novel Coronavirus: September 14 | BioSpace

AstraZeneca Plc’s Covid-19 vaccine trial remains on hold in the U.S. as regulators examine a serious side effect suffered by a U.K. patient, Reuters reported on Monday.

AstraZeneca trial on hold pending U.S. scrutiny, Reuters reports - BNN Bloomberg

Germany says it is providing up to 750 million euros (US$892 million) to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus.Germany says it is providing up to 750 million euros (US$892 million) to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus.

Germany boosts own vaccine makers in race for COVID-19 jab | CTV News

Where the UK has resumed the clinical tests of AstraZeneca's COVID-19 vaccine candidate following a review by the country's drug regulator and an independent safety review committee, trials paused in India, US, and South Africa are yet to resumeWhere the UK has resumed the clinical tests of AstraZeneca's COVID-19 vaccine candidate following a review by the country's drug regulator and an independent safety review committee, trials paused in India, US, and South Africa are yet to resume

Coronavirus vaccine update: What's the status of Oxford-Astra Zeneca trials in India, other countries